Cutaneous anthrax management algorithm

Journal of the American Academy of Dermatology

Volumn 47, Issue 5, 2002, Pages 766-769

  Carucci, John A ^a   McGovern, Thomas W ^a   Norton, Scott A ^a   Daniel, C Ralph ^a   Elewski, Boni E ^a   Fallon Friedlander, Sheila ^a   Lushniak, Boris D ^a   Taylor, James S ^a   Warschaw, Karen ^a   Wheeland, Ronald G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTHRAX VACCINE; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; IMIPENEM; PENICILLIN G; STEROID; TETRACYCLINE; VANCOMYCIN;

ANTHRAX; ANTIBIOTIC THERAPY; BACILLUS ANTHRACIS; BACTERIAL SKIN DISEASE; BONE DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG INDICATION; HUMAN; PATIENT CARE; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PUNCH BIOPSY; REVIEW; SIDE EFFECT; SKIN BIOPSY; TOOTH DISEASE; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0036827758     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.128381     Document Type: Article

References (10)

1. Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. N Engl J Med 1999;341:815-26. Also available at: URL:http://content.nejm.org/cgi/content/fall/341/11/815.
2. Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, et al. Anthrax as a biological weapon. JAMA 1999;281:1735-45. Also available at: URL:http://jama.ama-assn.org/issues/v281n18/ffull/jst80027.html.
3. Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. Anthrax as a biological weapon, 2002: Updated recommendations for management. JAMA 2002;287:2236-52.
4. McGovern TW, Christopher GW. Cutaneous manifestations of biological warfare agents. In: Drugge R, editor. The Electronic Textbook of Dermatology. The Internet Dermatology Society; 1999. Available at: URL:http://telemedicine.org/stamford.htm.
5. Notice to readers: Update: Recommendations for post-exposure prophylaxis and treatment of children and lactating women with Bacillus anthracis infections. MMWR Morb Mortal Wkly Rep 2001;50:1014.
6. Pittman PR, Gibbs PH, Cannon TL, Friedlander AM. Anthrax vaccine: Short-term safety experience in humans. Vaccine 2001;20:972-8.
7. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR Morb Mortal Wkly Rep 2001;50:889-93. Also available at: URL:http://www. cdc.gov/mmwr/preview/mmwrhtml/mm5041a1.htm.
8. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis. MMWR Morb Mortal Wkly Rep 2001;50:973-6. Also available at: URL:http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5044a1.htm.
9. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR Morb Mortal Wkly Rep 2001;50:941-8. Also available at: URL:http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5043a1. htm.
10. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep 2001;50:909-19. Also available at: URL:http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5042a1.htm.